U.S. National Library of Medicine
Hereditary multiple exostoses - Genetics Home Reference
Skip Navigation
About   Site Map   Contact Us
 
A service of the U.S. National Library of Medicine®
 
 
Printer-friendly version
Hereditary multiple exostoses

Hereditary multiple exostoses

Reviewed December 2007

What is hereditary multiple exostoses?

Hereditary multiple exostoses is a condition in which people develop multiple benign (noncancerous) bone tumors called exostoses. The number of exostoses and the bones on which they are located vary greatly among affected individuals. The exostoses are not present at birth, but approximately 96 percent of affected people develop multiple exostoses by the time they are 12 years old. Once people with hereditary multiple exostoses reach adult height and their bones stop growing, the development of new exostoses also usually stops.

Multiple exostoses can disrupt bone growth and can cause growth disturbances of the arms, hands, and legs, leading to short stature. Often these bone growth disturbances do not affect the right and left limb equally, resulting in uneven limb lengths (limb length discrepancy). Multiple exostoses may also result in pain, limited range of joint movement, and pressure on nerves, blood vessels, the spinal cord, and tissues surrounding the exostoses.

Exostoses are typically benign; however, in some instances these tumors become malignant (cancerous). Researchers estimate that people with hereditary multiple exostoses have a 1 in 20 to 1 in 200 lifetime risk of developing cancerous exostoses (sarcomas).

How common is hereditary multiple exostoses?

The incidence of hereditary multiple exostoses is estimated to be 1 in 50,000 individuals. This condition occurs more frequently, however, in some isolated populations. The incidence is approximately 1 in 1,000 in the Chamorro population of Guam and 1 in 77 in the Ojibway Indian population of Manitoba, Canada.

What genes are related to hereditary multiple exostoses?

Mutations in the EXT1 and EXT2 genes cause hereditary multiple exostoses. The EXT1 gene and the EXT2 gene provide instructions for producing the proteins exostosin-1 and exostosin-2, respectively. The two exostosin proteins bind together and form a complex found in a cell structure called the Golgi apparatus, which modifies newly produced enzymes and other proteins. In the Golgi apparatus, the exostosin 1 and 2 complex modifies a protein called heparan sulfate so it can be used by the cell.

When there is a mutation in exostosin-1 or exostosin-2, heparan sulfate cannot be processed correctly and is nonfunctional. Although heparan sulfate is involved in many bodily processes, it is unclear how the lack of this protein contributes to the signs and symptoms of hereditary multiple exostoses.

If the condition is caused by a mutation in the EXT1 gene it is called hereditary multiple exostoses type 1. A mutation in the EXT2 gene causes hereditary multiple exostoses type 2. While both type 1 and type 2 involve multiple exostoses, the severity of symptoms associated with exostoses seems to be greater in type 1.

Researchers estimate that about 15 percent of people with hereditary multiple exostoses have no mutation in either the EXT1 or the EXT2 gene. It is not known why multiple exostoses form in these people.

Read more about the EXT1 and EXT2 genes.

How do people inherit hereditary multiple exostoses?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In some cases, an affected person inherits the mutation from one affected parent. Other cases may result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.

Where can I find information about treatment for hereditary multiple exostoses?

These resources address the management of hereditary multiple exostoses and may include treatment providers.

You might also find information on treatment of hereditary multiple exostoses in Educational resources and Patient support.

Where can I find additional information about hereditary multiple exostoses?

You may find the following resources about hereditary multiple exostoses helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for hereditary multiple exostoses?

  • Bessel-Hagen disease
  • Diaphyseal Aclasis
  • Exostoses, Multiple Hereditary
  • Familial Exostoses
  • Multiple Cartilaginous Exostoses
  • Multiple Hereditary Exostoses
  • Multiple Osteochondromas
  • Multiple osteochondromatosis

What if I still have specific questions about hereditary multiple exostoses?

Where can I find general information about genetic conditions?

What glossary definitions help with understanding hereditary multiple exostoses?

autosomal ; autosomal dominant ; benign ; cell ; enzyme ; Exostoses ; familial ; gene ; Golgi apparatus ; Heparan Sulfate ; incidence ; joint ; mutation ; new mutation ; population ; protein ; sarcoma ; sign ; stature ; sulfate ; symptom ; tissue ; tumor

You may find definitions for these and many other terms in the Genetics Home Reference Glossary.

References (5 links)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? in the Handbook.

 
Reviewed: December 2007
Published: January 7, 2008

Be notified of page updates
it's private

ChangeDetection
Site Map
Wings of HOPE as we REACH
for the CURE to
Multiple Hereditary Exostoses / Multiple
Osteochondroma
Back

powered by FreeFind
Website Search
You need Java to see this applet.
The MHE Research Foundation, we comply with the HONcode standard for health trust worthy information: By the Health On the Net Foundation. Click
here
to verify.# HON Conduct 282463  and is linked on the NIH National Library of Medicine, Directory of Health Organizations (SIS) website, as well as
the link for Patient Information on
The Diseases Database a cross-referenced index of human disease, and the Intute: health & life sciences a free
online service  providing access to the very best Web resources for education and research located in the  UK
The MHE Research Foundation is proud to be working with the EuroBoNeT consortium, a European Commission granted Network of Excellence for
studying the pathology and genetics of bone tumors.
This website is regularly reviewed by members of the Scientific and Medical Advisory Board of the MHE Research Foundation.

All online submission forms use (SSL 3.0, RC4 with 128 bit encryption (High); RSA with 1024 bit exchange) Protocol with
Privacy protection.
Our goal is to make this website as safe and user friendly as possible.
The MHE Research Foundation is a participating member organization of the
United States Bone and Joint Decade,  (USBJD) & the  USBJD Rare Disease Patient Network
number of users on this website page now :

This web page was updated last on 6/21/09, 4:0O pm Eastern time
Written consent must be obtained to attach web pages or the files attached to this website. Please email webmaster.
Disclaimer:   While many find the information useful, it is in no way a substitute for professional medical care. The information provided here is for educational
and informational purposes only. This website does not engage in the practice of medicine. In all cases we recommend that you consult your own physician
regarding any course of treatment or medicine.
 
The MHE Research Foundation is proud to be an affiliate of the Society For Glycobiology